Treatment With PCSK9 Inhibitors Influence miRNAs Expression and Changes of Arterial Wall Properties

被引：0
|
作者：
Likozar, Andreja Rehberger
Ugovsek, Sabina
Levstek, Tina
Podkrajsek, Katarina Trebusak
Sebestjen, Miran
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
PCSK9; Endothelial function; Carotid arteries; Lipoproteins;
D O I：
10.1161/circ.148.suppl_1.16485
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16485
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Treatment with PCSK9 inhibitors influences microRNAs expression and changes of arterial wall properties: a randomized controlled trial
    Likozar, Andreja Rehberger
    Levstek, Tina
    Karun, Tina
    Podkrajsek, Katarina Trebusak
    Zupan, Janja
    Sebestjen, Miran
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2025, 30 (01)
  • [2] PCSK9 inhibitors
    Farnier, Michel
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (03): : 66 - 70
  • [3] PCSK9 inhibitors
    Farnier, Michel
    CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (03) : 251 - 258
  • [4] PCSK9 inhibitors
    Gencer, Baris
    Lambert, Gilles
    Mach, Francois
    SWISS MEDICAL WEEKLY, 2015, 145
  • [5] High glucose effects on PCSK9 expression in aortic VSMC: role of PCSK9 inhibitors
    Barale, C.
    Melchionda, E.
    Russo, I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S421 - S421
  • [6] The Role of PCSK9 Inhibitors in the Treatment of Hypercholesterolemia
    Patel, Roshni S.
    Scopelliti, Emily M.
    Olugbile, Oludamilola
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (10) : 1000 - 1018
  • [7] TREATMENT WITH PCSK9 INHIBITORS IN PERITONEAL DIALYSIS
    Areste-Fosalba, Nuria
    Diaz-Diez, Irene
    Klimek, Kamila
    Angel Ramirez-Lopez, Miguel
    Salgueira-Lazo, Mercedes
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [8] Effects of PCSK9 Inhibition on Plasma PCSK9 Concentration and Hepatic PCSK9 Expression
    Shapiro, Michael D.
    Tavori, Hagai
    Oleaga, Carlota
    Miles, Joshua
    Fazio, Sergio
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [9] Improvement in arterial stiffness after short-term treatment with PCSK9 inhibitors
    Cicero, A. F. G.
    Toth, P. P.
    Fogacci, F.
    Virdis, A.
    Borghi, C.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2019, 29 (05) : 527 - 529
  • [10] Safety of PCSK9 inhibitors
    Grzesk, Grzegorz
    Dorota, Bednarska
    Wolowiec, Lukasz
    Wolowiec, Anna
    Osiak, Joanna
    Kozakiewicz, Mariusz
    Banach, Joanna
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
12345